Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Pál Magyar"'
Autor:
György Fekete, Krisztina Kádár, Mária Katona, Angela Dajnoki, Krisztina Németh, Veronika Müller, Éva Rákóczi, Beáta Tóth, Dániel Bereczki, Sarolta Kárpáti, Rita Széchey, Gábor Rudas, Miklós Garami, Pál Magyar, Attila Kertész, László Maródi, Gergely Bokrétás, Vera Gulácsy, Mohamed Mahdi, Orsolya Fiedler, Edit Varga, Viktor Nagy, Ildikó Vastagh, Annamária Székely, Andrea Ponyi, Sándor Molnár, Csaba Ambrus, Márta Medvecz, Tamás Constantin, Melinda Erdős
Publikováno v:
Orvosi Hetilap. 151:1243-1251
A Fabry-kór a lizoszomális tárolási betegségek csoportjába tartozó, X-kromoszómához kötötten, recesszív módon öröklődő betegség, amely a globotriaozilceramid felhalmozódásához vezet a szervezet legkülönbözőbb szöveteiben. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97961ba4eb94bea0f92b65da36d91ea5
https://doi.org/10.1556/oh.2010.28796
https://doi.org/10.1556/oh.2010.28796
Publikováno v:
Expert Opinion on Drug Safety. 8:9-14
The efficacy of cisplatin-vinorelbine chemotherapy (CT) in NSCLC is well established. In this retrospective data analysis, haematological safety and tolerability, furthermore the effects of cisplatin-vinorelbine combination on patients' quality of li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2048c2971a2b4dc240cc601b8dbec3c0
https://doi.org/10.1517/14740330802521771
https://doi.org/10.1517/14740330802521771
Publikováno v:
Magyar Onkológia. 52:179-183
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6218341b5d8f8fd31127cf7c3f93a047
https://doi.org/10.1556/monkol.52.2008.2.6
https://doi.org/10.1556/monkol.52.2008.2.6
Kissejtes tüdőrákban szenvedő betegek hatékony eritropoetikus protein kezelése – Saját tapasztalatok
Publikováno v:
Magyar Onkológia. 52:43-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb5289c130981993ac41fa96c06a9cc4
https://doi.org/10.1556/monkol.52.2008.1.6
https://doi.org/10.1556/monkol.52.2008.1.6
Autor:
Ilona Vinkler, Pál Magyar, Renate Engelstätter, Michelle Vivienne Middle, Cezary Rybacki, Armella Escher, Roland Buhl, Zsuzsa Györi
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 19:404-412
Background Inhaled corticosteroids are the mainstay of therapy in asthma, but local and systemic side effects and adherence remain a concern. Ciclesonide is an inhaled corticosteroid with on-site lung activation that provides potent anti-inflammatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f595b409a0a46b998c773e0b5f2bad7
https://doi.org/10.1016/j.pupt.2005.10.003
https://doi.org/10.1016/j.pupt.2005.10.003
Autor:
Veronika Müller, G. Losonczy, Anikó Bohács, Lilla Tamási, Zsolt István Komlósi, András Falus, Éva Pállinger, János Rigó, Pál Magyar
Publikováno v:
Clinical Experimental Allergy. 35:1197-1203
Summary Background Pregnancy frequently interferes with the course of bronchial asthma, and asthmatic pregnant women experience less successful pregnancies. T lymphocytes synthesizing IL-4 or IFN-γ are important in allergic mechanisms of the airways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a416e8b4409a8acfa0cf77e6f3398c
https://doi.org/10.1111/j.1365-2222.2005.02322.x
https://doi.org/10.1111/j.1365-2222.2005.02322.x
Publikováno v:
Allergy. 58:624-628
Background: The objective was to develop an educational instrument, to assess its impact as an intervention instrument and to examine quality of life (QoL). Methods: 119 asthmatics were randomized (64 in the intervention and 55 in the reference group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e76de9ba4a83812a83ea113add71f8
https://doi.org/10.1034/j.1398-9995.2003.00207.x
https://doi.org/10.1034/j.1398-9995.2003.00207.x
Publikováno v:
Allergologie. 26:225-230
Background:The objective was to determine the correlation rate between 2 different instruments measuring quality of life (QoL) of adult asthmatics. Methods:We examined the QoL of 321 asthmatic patients with a disease specific instrument, the St. Geor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4890429a0978317ffbb7a4c180ced6f6
https://doi.org/10.5414/alp26225
https://doi.org/10.5414/alp26225
Autor:
Evo Alemao, Karoly Dobos, Kalman Gyurkovits, Pál Magyar, Iren Herjavecz, Laszlo Nagy, Rami Ben-Joseph, Gyorgy Boszormenyi Nagy
Publikováno v:
Journal of Asthma. 40:673-681
To assess asthma-related morbidity, symptom control, and societal cost of asthmatic patients in Hungary. Secondary objective was to assess the relationship between asthma symptom control and costs incurred.Three hundred seventy-eight pediatric asthma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e2f47c91d0c0fd7076e690a80b27f1
https://doi.org/10.1081/jas-120021100
https://doi.org/10.1081/jas-120021100
Autor:
Akos Somoskovi, Pál Magyar
Publikováno v:
Journal of Clinical Microbiology. 37:1366-1369
The rate of recovery and the mean time to detection of mycobacteria in clinical specimens were evaluated with two nonradiometric broth-based systems, the Mycobacteria Growth Indicator Tube (MGIT) and MB Redox systems. The data obtained for each syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a5566842dc19fb496484377d6aecc30
https://doi.org/10.1128/jcm.37.5.1366-1369.1999
https://doi.org/10.1128/jcm.37.5.1366-1369.1999